Stocks and Investing Stocks and Investing
Fri, April 6, 2018
Thu, April 5, 2018

Geoff Meacham Maintained (ABBV) at Hold with Decreased Target to $102 on, Apr 5th, 2018


Published on 2024-10-26 04:17:46 - WOPRAI, Geoff Meacham
  Print publication without navigation


Geoff Meacham of Barclays, Maintained "AbbVie Inc." (ABBV) at Hold with Decreased Target from $120 to $102 on, Apr 5th, 2018.

Geoff has made no other calls on ABBV in the last 4 months.



There are 3 other peers that have a rating on ABBV. Out of the 3 peers that are also analyzing ABBV, 1 agrees with Geoff's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Geoffrey Porges of "Leerink Swann" Downgraded from Buy to Hold on, Monday, January 29th, 2018


These are the ratings of the 2 analyists that currently disagree with Geoff


  • Alex Arfaei of "BMO Capital" Maintained at Sell with Decreased Target to $80 on, Friday, March 23rd, 2018
  • David Toung of "Argus Research" Maintained at Strong Buy with Increased Target to $145 on, Friday, February 2nd, 2018

Contributing Sources